Match Document Document Title Score
US20100016262 Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis  
The present invention relates to the discovery that acetylsalicylic acid (ASA or aspirin), salicylic acid (SA) and related salicylate esters and their pharmaceutically acceptable salts, when...
50
US20120115782 COMPOSITIONS AND METHODS FOR TREATING OR INHIBITING LIVER INJURY  
The present invention relates to the discovery that acetylsalicylic acid (ASA or aspirin), salicylic acid (SA) and related salicylate esters and their pharmaceutically acceptable salts, when...
50
6747003 Modified vitamin K-dependent polypeptides  
The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot...
50
US20170301197 Emergency Responder Alert System  
A kit and a systematic method for alerting emergency responders of an exact location in which they have been dispatched. The system includes a container for holding medication, a strobe light and...
50
8070796 Thrombosis inhibiting graft  
A medical method that is adapted for introducing the medical device into the vascular system of a body which is designed to inhibit or prevent thrombosis after the insertion of the medical device.
49
5861399 Methods and compositions for the rapid and enduring relief of inadequate myocardial function  
Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse...
49
3894655 Plastic container  
An integrally formed, one-piece, generally rectangular, plastic container particularly adapted for holding medicines. The container includes a generally rectangular bottom section which is...
49
4133449 Plastic container  
An integrally formed, one-piece, generally rectangular, plastic container particularly adapted for holding medicines is disclosed. The container includes a generally rectangular bottom section...
49
US20170319521 EXTENDED, DELAYED AND IMMEDIATE RELEASE FORMULATION METHOD OF MANUFACTURING AND USE THEREOF  
Compositions for reducing the frequency of urination and methods of manufacturing the compositions are disclosed. The compositions comprises a first component having an immediate-release...
49
US20170319520 EXTENDED, DELAYED AND IMMEDIATE RELEASE FORMULATION METHOD OF MANUFACTURING AND USE THEREOF  
Compositions for reducing the frequency of urination and methods of manufacturing the compositions are disclosed. The compositions comprises a first component having an immediate-release...
49
US20150374651 EXTENDED, DELAYED AND IMMEDIATE RELEASE FORMULATION METHOD OF MANUFACTURING AND USE THEREOF  
Compositions for reducing the frequency of urination and methods of manufacturing the compositions are disclosed. The compositions comprises a first component having an immediate-release...
49
US20140323429 NSAIDS-INDUCED GASTROINTESTINAL MUCOSAL DISORDER ALLEVIATOR AND MANUFACTURING METHOD THEREOF  
A method of manufacturing a medical drug of alleviating damage of gastrointestinal mucosal induced by a non-steroidal anti-inflammatory drug, NSAID, the medical drug being able to induce...
49
US20070032864 Thrombosis inhibiting graft  
A medical method that is adapted for introducing the medical device into the vascular system of a body which is designed to inhibit or prevent thrombosis after the insertion of the medical device.
49
US20100042206 BIOABSORBABLE COATINGS FOR MEDICAL DEVICES  
A medical device that is designed to be introduced into a vascular system of a body.
48
US20070112414 System and method for local delivery of antithrombotics  
Dipyridamole is an antithrombotic agent which also promotes the growth of endothelial cells. An endothelial cell lining within a stent is necessary for complete healing on the interior of the...
48
US20140234423 PROGRAMMING OF CELLS FOR TOLEROGENIC THERAPIES  
Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation....
48
4546881 Tamperproof packaging  
A tamperproof package for containers of ingestible material such as aspirin, nonprescription drugs, food products and the like, comprising a thin layer of an elastomeric material stretched thinly...
48
US20080161275 Compositions and methods for the treatment of inflammatory disease  
The invention relates to methods of treating inflammatory disease comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound.
48
7241456 Formulations for topical delivery of bioactive substances and methods for their use  
The invention relates to topical delivery of bioactive agents. More particularly, the invention relates to anhydrous formulations for percutaneous absorption. The invention provides formulations...
48
10023913 SR-BI as a predictor of elevated high density lipoprotein and cardiovascular disease  
The present invention relates to the field of single nucleotide polymorphisms (SNPs) and uses therefore as a predictor of diseases and conditions. Specifically, the present invention provides...
48
4153691 Analgesic and anti-inflammatory compositions  
A pharmaceutical composition having analgesic, anti-pyretic and anti-inflammatory activity and administration thereof in oral dosage form, comprising 2-(carbamoyl)phenyl-2-acetoxybenzoate as...
48
US20120288561 DELAYED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
48
US20120237574 DELAYED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
48
US20070116756 STABLE PHARMACEUTICAL COMPOSITIONS  
A pharmaceutical dosage form, comprising an outer capsule containing at least one capsule, tablet, and/or particles comprising different drug substances.
48
US20130224175 RECOMBINANT THERAPEUTIC GLYCINE N-ACYLTRANSFERASE  
This invention relates to a method of producing a recombinant enzyme, more particularly, this invention relates to a method of producing water soluble enzymatically active recombinant glycine...
48
US20180250282 Novel Methyl-Piperidine Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1  
The present invention provides compounds of Formula 1, or a pharmaceutically acceptable salt thereof, where R, R1, and G are as described herein; methods of preparing the compounds; and use of the...
47
US20180251446 Novel Carboxylic Acid Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1  
The present invention provides compounds of Formula 1, or a pharmaceutically acceptable salts, thereof, where R, X, A, E, and G are as described herein, methods of preparing the compounds, and use...
47
1969998 Combination of salicylic acid and calcium salts   47
US20140024624 Method of Ameliorating Clotting Pathologies and Related Materials and Methods  
Methods for reducing blood clotting in a subject are provided, including methods to reduce the risk of and/or treat blot clotting pathologies. Also provided are compositions useful to reduce the...
47
9554984 Oral care compositions for topical application  
The invention provides a biological dressing for treatment of a condition of the skin, mucosa, teeth or other tissue within or proximate to the oral cavity of a subject, the biological dressing...
47
US20070243251 Dosage Forms Containing A PPI, NSAID, and Buffer  
Provided herein, are dosage forms comprising an NSAID, a buffer and a PPI, as well as methods of treating various maladies using the above dosage form.
47
US20090074863 Dosage Forms Containing A PPI, NSAID And A Buffer  
Provided herein, are dosage forms comprising an NSAID, a buffer and a PPI, as well as methods of treating various maladies using the above dosage form.
47
US20090075950 Dosage Forms Containing A PPI, NSAID And A Buffer  
Provided herein, are dosage forms comprising an NSAID, a buffer and a PPI, as well as methods of treating various maladies using the above dosage form.
47
US20040131676 Dosage forms containing a PPI, NSAID, and buffer  
Provided herein, are dosage forms comprising an NSAID, a buffer and a PPI, as well as methods of treating various maladies using the above dosage form.
47
US20040121004 Dosage forms containing a PPI, NSAID, and buffer  
Provided herein, are dosage forms comprising an NSAID, a buffer and a PPI, as well as methods of treating various maladies using the above dosage form.
47
US20100099642 TGF-BETA STIMULANT AND FURTHER AGENT TO REDUCE SIDE EFFECTS  
The invention relates to the use of TGF-beta stimulating agents, and in particular members of the triphenylethylene class of pharmaceutical agents, for the prevention, prophylaxis, treatment or...
47
8981059 Platelet aggregation inducing substance  
A platelet aggregation inducing substance containing as an active ingredient a polypeptide having a peptide fragment represented by formula (1) (component A): -(Pro-X-Gly)n- (1) wherein X...
47
9226892 pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same  
Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or...
46
10172847 Method for reducing, inhibiting, and eliminating inflammation and pain with transdermal delivery of iron chelator composition  
A method for reducing, inhibiting, and eliminating inflammation and pain by using an effective amount of iron chelator composition to balance oxidative activity at a cutaneous site of inflammation...
46
5110606 Non-aqueous microemulsions for drug delivery  
Palatable liquid therapeutic microemulsion wherein a drug dissolved in propylene glycol is dispersed in fatty ester. Lecithin is the emulsifier.
46
7495019 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use  
The present invention relates to new bisbenzisoselenazolonyl derivatives of the following general formulae (I), (II) or (III) and their pharmaceutically acceptable salts. The inventive derivatives...
46
5032575 Method for enhancing healing of corneal endothelial wounds  
Method using a non-steroidal antiinflammatory compound, such as indomethacin and/or a growth factor that causes a change in cell function when bound to a specific cell surface receptor, such as...
46
8765723 Analogues of cilostazol  
This invention relates to novel compounds which are derivatives of the phosphodiesterase inhibitor, cilostazol and pharmaceutically acceptable salts thereof. This invention also provides...
46
6403571 Combination therapy for reducing the risks associated with cardiovascular disease  
The instant invention involves a combination therapy and pharmaceutical compositions comprised of a therapeutically effective amount of a cholesterol reducing agent such as an HMG-CoA reductase...
46
9321785 Methods for the treatment or prophylaxis of thrombosis or embolism  
The present invention relates to a method of ameliorating the drawbacks of anti-platelet drug named clopidogrel. The method of the present invention comprises administration of an...
46
US20040219240 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity  
The invention provides hops (Humulus lupulus) extracts or derivatives thereof for use in treating a patient prophylactically and/or therapeutically for ulcerogenic-type disorders of the stomach...
46
9937141 Carcinoma diagnosis and treatment, based on ODC1 genotype  
The present invention provides methods and kits a) for predicting colorectal cancer patient survival, as well as the survival of patients harboring other invasive cancers where cellular...
46
8367645 Compositions and methods for treating hyperproliferative diseases  
The invention relates to a composition that includes a first agent selected including an agent that possesses anti-inflammatory activity or acetaminophen, phenacetin, tramadol and the like; a...
45
5466865 Neomorphic ibuprofen and methods of using same  
A novel neomorphic form of ibuprofen, processes for preparing the ibuprofen, and method for administering the ibuprofen are provided. The neomorphic form is characterized by having a distinctively...
45
US20180318355 METHODS AND COMPOSITIONS FOR IMPROVED TISSUE REGENERATION BY SUPPRESION OF INTERFERIN-GAMMA AND TUMOR NECROSIS FACTOR-ALPHA  
The present invention discloses methods, compositions and devices for improving tissue regeneration by suppressing the effects of several proinflammatory cytokines such as TNF-α and IFN-γ....
45


Search
« search again